Canopy Growth Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff Motion.
LOS ANGELES, April 16, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Canopy Growth Corporation ('Canopy' or the 'Company') (NYSE: ATKR) investors of a class action representing investors that bought securities between May 30, 2024 and February 6, 2025, inclusive (the 'Class Period'). Canopy Growth Corporation investors have until June 3, 2025 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses.
On February 7, 2025, Canopy Growth released its financial results for the third quarter of fiscal year 2025, falling short of consensus estimates. The Company reported a 400 basis point decline in gross margin, bringing it down to 32%. Canopy attributed the decrease to increased costs associated with the launch of its Claybourne infused pre-rolls in Canada, as well as higher indirect costs related to its Storz & Bickel vaporizer devices.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
[email protected]
310-692-8883
www.portnoylaw.com
Attorney Advertising
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Bullish (BLSH) Soars Anew on Strong Buying
We recently published . Bullish (NYSE:BLSH) is one of the top performers on Thursday. Cryptocurrency exchange Bullish saw its share prices grow by 9.75 percent on Thursday to close at $74.63 apiece as investors continued to post strong confidence in the company. After its debut on the stock market on Wednesday, August 13, shares of Bullish (NYSE:BLSH) already rose by a whopping 219 percent from its $37 IPO price, to an intra-day high of $118, before paring gains to finish lower. PTstock/ The company successfully raised $1.1 billion in fresh funds from its IPO, covering 30 million shares or 19.9 percent of its total stock. As of Thursday, it was valued at nearly $11 billion. Bullish (NYSE:BLSH) joins the roster of publicly listed cryptocurrency exchange platforms, taking advantage of President Donald Trump's favorable attitude towards the cryptocurrency industry. Unlike most crypto exchanges, Bullish (NYSE:BLSH) primarily caters to institutional clients, offering spot trading, margin trading, and crypto derivatives, targeting the stable and recurring revenue stream that institutional investors provide. While we acknowledge the potential of BLSH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
26 minutes ago
- Yahoo
Manning & Napier Group, LLC Significantly Increases Stake in UnitedHealth Group Inc
Exploring the Strategic Moves of Manning & Napier Group, LLC (Trades, Portfolio) in Q2 2025 Warning! GuruFocus has detected 7 Warning Sign with MSFT. Manning & Napier Group, LLC (Trades, Portfolio) recently submitted its 13F filing for the second quarter of 2025, offering a glimpse into its strategic investment decisions during this period. Manning & Napier (NYSE: MN) is renowned for providing a wide array of investment solutions, including separately managed accounts, mutual funds, and collective investment trust funds. Established in 1970, the firm has a long-standing reputation for its proprietary bottom-up investment process, which has been instrumental in building diversified portfolios. Serving a diverse clientele, including high-net-worth individuals and institutions, Manning & Napier is committed to delivering customized solutions that address specific client needs. The firm's investment approach involves a rigorous evaluation process, ensuring that each security aligns with its strategic fit and valuation criteria. Summary of New Buy Manning & Napier Group, LLC (Trades, Portfolio) added a total of 55 stocks, among them: The most significant addition was Ferrari NV (NYSE:RACE), with 267,825 shares, accounting for 1.57% of the portfolio and a total value of $131.43 million. The second largest addition to the portfolio was Workday Inc (NASDAQ:WDAY), consisting of 515,367 shares, representing approximately 1.47% of the portfolio, with a total value of $123.69 million. The third largest addition was Amphenol Corp (NYSE:APH), with 990,350 shares, accounting for 1.17% of the portfolio and a total value of $97.80 million. Key Position Increases Manning & Napier Group, LLC (Trades, Portfolio) also increased stakes in a total of 106 stocks, among them: The most notable increase was UnitedHealth Group Inc (NYSE:UNH), with an additional 551,603 shares, bringing the total to 617,787 shares. This adjustment represents a significant 833.44% increase in share count, a 2.05% impact on the current portfolio, with a total value of $192.74 million. The second largest increase was Sherwin-Williams Co (NYSE:SHW), with an additional 196,678 shares, bringing the total to 208,904. This adjustment represents a significant 1,608.69% increase in share count, with a total value of $71.73 million. Summary of Sold Out Manning & Napier Group, LLC (Trades, Portfolio) completely exited 39 holdings in the second quarter of 2025, as detailed below: Globant SA (NYSE:GLOB): Manning & Napier Group, LLC (Trades, Portfolio) sold all 907,659 shares, resulting in a -1.32% impact on the portfolio. Albemarle Corp (NYSE:ALB): Manning & Napier Group, LLC (Trades, Portfolio) liquidated all 1,167,520 shares, causing a -1.04% impact on the portfolio. Key Position Reduces Manning & Napier Group, LLC (Trades, Portfolio) also reduced positions in 134 stocks. The most significant changes include: Reduced Johnson & Johnson (NYSE:JNJ) by 904,444 shares, resulting in a -77.51% decrease in shares and a -1.85% impact on the portfolio. The stock traded at an average price of $153.90 during the quarter and has returned 18.48% over the past 3 months and 23.55% year-to-date. Reduced Meta Platforms Inc (NASDAQ:META) by 255,982 shares, resulting in a -44.83% reduction in shares and a -1.82% impact on the portfolio. The stock traded at an average price of $617.26 during the quarter and has returned 22.16% over the past 3 months and 34.45% year-to-date. Portfolio Overview At the end of the second quarter of 2025, Manning & Napier Group, LLC (Trades, Portfolio)'s portfolio included 303 stocks. The top holdings included 3.98% in Microsoft Corp (NASDAQ:MSFT), 3.14% in Inc (NASDAQ:AMZN), 2.99% in Alphabet Inc (NASDAQ:GOOGL), 2.79% in Mastercard Inc (NYSE:MA), and 2.77% in Meta Platforms Inc (NASDAQ:META). The holdings are mainly concentrated in all 11 industries: Technology, Financial Services, Healthcare, Industrials, Consumer Cyclical, Communication Services, Basic Materials, Consumer Defensive, Energy, Real Estate, and Utilities. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Salesforce Rallies As Investors Bet On Refocus And Margin Expansion
Salesforce (NYSE:CRM) shares climbed Friday as renewed investor optimism signaled a potential turning point for the software giant, which has faced slowing growth, rising competition, and mounting pressure to refocus on its core cloud business. DA Davidson analyst Gil Luria upgraded Salesforce (NYSE:CRM) from Underperform to Neutral with a price forecast of $225 on Friday. Luria upgraded Salesforce to Neutral from Underperform but kept his $225 price forecast, valuing the company at 18.5x his updated fiscal 2027 EPS said Salesforce has trailed the iShares Expanded Tech-Software Sector ETF (BATS:IGV) by 48 points year-to-date and 27 points since its fiscal first-quarter 2026 earnings on May 28, as investor sentiment soured over slowing organic growth in its core business and intensifying competition across its customer base. Luria projected Salesforce's organic revenue growth at 8% in fiscal 2026 and 7% in fiscal 2027 (excluding Informatica (NYSE: INFA)), warning that the company's push into Agentforce is coming at the expense of its core cloud business. He said Salesforce's fiscal second-quarter 2026 guidance, the first quarter in its history where cRPO growth is expected to be under 10% in constant currency, confirms mounting headwinds from market saturation, competitive pressure, and customer budget scrutiny. He noted that while Agentforce adoption has been strong, bottlenecks such as tech debt, siloed data, unpredictable costs when AI is enabled, and unclear enterprise AI strategies limit the efficiency gains investors expect. Luria said activist investor Starboard Value recently boosted its stake by 47%, which he sees as a signal of renewed pressure on Salesforce to refocus on core growth, expand margins, and avoid dilutive acquisitions. Luria projected fiscal second-quarter 2026 revenue of $10.08 billion and EPS of $2.78. Price Actions: CRM shares traded higher by 2.65% to $239.55 at last check Friday. Photo by NYCStock via Shutterstock Latest Ratings for CRM Date Firm Action From To Mar 2022 Wedbush Maintains Outperform Mar 2022 Canaccord Genuity Maintains Buy Mar 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for CRM View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? SALESFORCE (CRM): Free Stock Analysis Report This article Salesforce Rallies As Investors Bet On Refocus And Margin Expansion originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
